MedTrace Logo

Effects of Intracoronary Prourokinase on the Coronary Flow During Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction

NCT02131220 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 362

Last updated 2018-08-07

No results posted yet for this study

Summary

The purpose of this study is to determine whether intracoronary selective thrombolysis are more effective than tirofiban on the coronary flow during primary percutaneous coronary intervention for the acute myocardial infarction.

Conditions

Interventions

DRUG

Prourokinase

20mg intracoronary bolus infusion using selective catheter during PCI

DRUG

Tirofiban

10ug/kg intracoronary bolus infusion using selective catheter during PCI

DRUG

normal saline

intracoronary bolus infusion using selective catheter during PCI

Sponsors & Collaborators

  • Fudan University

    lead OTHER

Principal Investigators

  • Junbo Ge, M.D. · Department of Cardiology, Zhongshan Hospital, Fudan University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2017-08-31
Completion
2017-09-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02131220 on ClinicalTrials.gov